Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study. uri icon

authors

  • Pivonello, Rosario
  • Moraitis, Andreas G
  • Irina Bancos, MD
  • Feelders, Richard A
  • Kargi, Atil Y
  • Kerr, Janice M
  • Gordon, Murray B
  • Mariash, Cary N
  • Terzolo, Massimo
  • Ellison, Noel

publication date

  • April 27, 2022